July 20, 2019

There have been many new drugs for diabetes in the last 10-12 years. It seems like we get one drug in a class, and then we suddenly have 3 or 4 and the class grows by leaps and bounds; just look at the GLP-1 Analogs as an example. I often wonder why no one has come up with a better metformin, as that seems like a giant market to conquer. This week Usif Darwish, PharmD Candidate, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences brings us phase 3 research on a new drug in a new class that seems to work like metformin, but can also be taken with metformin. We first brought you information on this drug in 2013, and now it looks like this one may make it all the way to the finish line.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief